Services

Value communication and launch preparation

VALUE DEMONSTRATION

  • Value dossier development and writing
  • Payer value propositions
  • Value communication tools

LAUNCH PREPARATION

  • Launch sequencing and planning
  • Price strategy development

ACCESS STRATEGY

  • Access launch strategy creation
  • Reimbursement strategy development

TENDER STRATEGY

  • Tender mapping
  • Tender strategy development
  • Tender pricing analysis
  • Tender submission writing

Payer and reimbursement insights

Clinical demand definition

  • Modified Delphi research
  • 1:1 interviews
  • Online surveys
  • Guided discussions

Expert validation

  • Economic model input and output validation
  • Reimbursement dossier validation

Payer workshops and advisory boards

  • Mixed use research
  • Group pricing studies
  • ‘Place in therapy’ workshops

Pricing, reimbursement, and HTAs

Health economic modelling

  • Cost effectiveness modelling
  • Budget impact modelling
  • Cost minimisation modelling

Pricing

  • Pricing research
  • International reference pricing analysis
  • Therapeutic product profile research
  • Forecast development

Health Technology Assessment and pricing and reimbursement submissions

  • HTA submissions
  • Pricing and reimbursement submissions

Health economics and data analytics

Health economic modelling

  • Cost effectiveness modelling
  • Budget impact modelling
  • Cost minimisation modelling

Data synthesis

  • Network meta analyses
  • Indirect treatment analyses
  • Systematic and targeted literature reviews

Real world evidence generation for market access

  • Burden of illness studies
  • Resource utilisation studies
  • Chart review and registry planning

Asset evaluation

In-licensing

  • Price evaluation
  • Forecasting
  • Reimbursement strategy development

Product Development

  • International reference pricing analysis
  • Therapeutic product profile research
  • Forecast development

Reimbursement testing

  • Assessment of likely reimbursement

What our clients say about us

The team at Initiate just get on with it! That makes life very easy for me, knowing that your expertise will help me to achieve.

General Manager, top 20 Pharma

We hired you to help us through a short-term hiatus in resource. You picked up the project and owned it, feeling everything personally. You delivered way ahead of expectations. We will use your team again and again. Thank you!

Global Director, Market Access

We don’t have in-house market access teams because Initiate can provide such great support. The team amazed us with their ideas and approaches to creating a model that shows cost effectiveness.

General Manager, EU Pharma

The modified Delphi work was crucial in setting the scene and closing the deal on positioning this product. We felt we were starting in a position of risk of failure until the authority accepted the modified Delphi, without which we would not have had a positive recommendation.

Market Access Director, top 10 Pharmaceutical Company

Until now, we didn’t have the frameworks in place to ensure co-creation and ownership for affiliate teams. Your work with all stakeholders has been transformational – we can now focus on the right things for our launches, knowing that we are all aligned on pricing and process.

VP Global Commercial Operations, Oncology Speciality Biotech Company

You are the 3rd agency to try to achieve reimbursement for this product and have succeeded where others have failed. Because of your ability to simplify the situation and make the payers more pragmatic, a number of people in this country will now have a chance to extend their life. Thank you.”

Market Access Director, EU Pharma

Our client partnerships

Our expertise is built upon long-standing client partnerships with global pharmaceutical, biotech, device, and diagnostic companies.